Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
It’s no surprise that an underperforming site can cause significant delays in meeting important accrual targets, data timelines, or study…
The Global Clinical Trials Market was valued at $44.3B USD in 2020, and by 2028 is expected to reach $69.3B…
The COVID-19 pandemic has required the clinical research industry to find new and innovative ways to monitor investigative sites. Although…
Nearly every aspect of society, including the way scientists conduct the testing of medicines has been affected by the COVID-19…
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
Pediatric Hematology Oncology is a relatively recent area of study. Only in the past 50 years have substantial advances taken…
This time last year none of us imagined we were about to go through a year like no other, and…